Skip to content

Nutrition for Precision Health, Powered by the All of Us

Nutrition for Precision Health, Powered by the All of Us Research Program

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05701657
Enrollment
8000
Registered
2023-01-27
Start date
2023-04-14
Completion date
2027-02-25
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Habits, Health, Nutrition

Brief summary

The goal of this Nutrition for Precision Health (NPH) powered by All of Us research study is to develop Artificial Intelligence/Machine Learning (AI/ML) algorithms that predict individual responses to diet patterns using rich multimodal data streams collected across multiple domains (e.g., behavior, social, environmental, clinical and molecular biomarkers). NPH includes a large phenotyping cohort (Module 1, N=8000) and two separate follow-up groups drawn from a subset of Module 1participants. One group (Module 2, N=1200) receives three distinct diets in a 14-day crossover sequence, with at least a 14-day washout period between diets, while living in their own homes. A second group (Module 3, N=150) receives the same three diets under full-time supervision in a residential research setting. We will train and test AI/ML models to predict 0-4 hour postprandial response curves for glucose, insulin, triglycerides, and GLP-1, to the standardized diet-specific meal test (DSMT) collected after each of the three different diets delivered in Module 2. Each diet functions as a controlled stimulus to reveal biological features (such as individual variables, patterns, or clusters of measurements) that best predict a person's response. The Module 2 DSMT response curves are the primary outcomes (dependent variables) for AI/ML algorithms that predict individual responses to diet patterns. As a secondary objective, NPH will evaluate the validity and acceptability of technology-based dietary assessment tools. The Automated Self-Administered 24-hour recall (ASA24), Automatic Ingestion Monitor-2 (AIM-2), and the mobile food record (mFR) will be evaluated in Modules 2 and 3, and the ASA24 food record and the image-assisted ASA24 recall will be evaluated only in Module 3. Total energy intake, macronutrient and dietary fiber intake data are the main outcomes for validity testing compared against measures of actual intake. Acceptability will be determined from feedback surveys.

Detailed description

The Nutrition for Precision Health (NPH) study is a multi-module, large-scale project with observational and interventional components embedded in the All of Us Research Program. The overarching goal is to develop artificial intelligence and machine learning (AI/ML) algorithms that predict individual responses to different diet patterns. The study consists of three modules designed to balance breadth (large scale phenotyping) and depth (controlled dietary interventions): Module 1: Phenotyping (non-interventional) Module 2: Community-dwelling controlled feeding group (Intervention arm 1) Module 3: Residential (Live-in) controlled feeding group (Intervention arm 2) Approximately 8,000 participants are anticipated to be enrolled in Module 1. From this cohort, approximately 1,200 participants will enroll in Module 2, and a separate subset of Module 1 participants (approximately 150 participants) will enroll in Module 3. Module 1 is observational and only Modules 2 and 3 are interventional in nature (intervention arms). Module 1 is a phenotyping observational study. Participants undergo comprehensive characterization across an 8 to 10-day baseline period for assessments including: clinical measures, biospecimen collection, wearable sensor monitoring, questionnaires, and a liquid meal test (LMT). During the LMT, participants ingest a standardized liquid meal with a dose of acetaminophen for estimating gastric emptying and provide timed blood samples for postprandial profiling. The LMT is a diagnostic stimulus used solely for feature generation and is not being evaluated as an intervention. The resulting Module 1 high dimensional dataset supports machine learning methods (e.g., PCA, clustering, recursive feature elimination) for candidate predictor discovery and is therefore not listed in the Arms/Interventions section. Module 1 data will be used to develop novel statistical and machine learning methods to learn individual and generalizable causal models of nutrition and health, particularly in the presence of missing or incomplete data. The scale of Module 1 enables discovery of causal pathways and moderators between physical and contextual measures, LMT responses, and continuous glucose monitoring (CGM) data. These insights are critical for developing models that not only predict individual dietary responses but also explain why and under what conditions they occur. Module 2 is a community dwelling controlled feeding arm (Intervention arm 1). A subset of Module 1 participants will enroll in Module 2, in which participants consume three standardized eucaloric diets; Diet A, Diet B, Diet C, in a crossover sequence. Each diet period lasts 12-14 days, separated by a minimum of 14-day washout period between diets. All meals are provided, but participants remain in their community dwelling environments. Participants undergo one of six possible sequences of dietary interventions, reflecting all possible orderings of the three diets (ABC, ACB, BCA, BAC, CAB, and CBA). To reduce potential bias, all six diet sequences are included in the crossover design. Rather than assigning diet sequences to individual participants, a cohort-based randomization approach is used to reduce operational burden on the metabolic kitchens. In this approach, pre-generated schedules involving all 6 diet sequences are randomly assigned to the clinical site metabolic kitchens, with each diet sequence corresponding to a cohort. Participants are then enrolled into the cohorts. The six diet orders are repeated over time at each site until the full enrollment targets for Modules 2 and 3 are met. Each site follows a different randomized version of the overall cohort schedule, which ensures distribution of the possible diet orders across time and clinical sites while preserving balance and logistical feasibility. Wearable-generated data (like accelerometry and CGM), physical and contextual measures are collected throughout. At the completion of each diet participants are provided a standardized breakfast meal test, DSMT, from each of the three provided diets (Diet A, B, C). The 0-4 hour postprandial response curves are then used to evaluate inter-individual variation and unmask features collected in Module 1 and 2 that contribute to the AI/ML predictions of the response. Each breakfast serves as a controlled stimulus to reveal underlying biological features from rich multimodal data streams, including clinical, molecular, behavioral, environmental, and social domains that may drive interindividual variability in metabolic response. For each DSMT, participants provide blood samples for up to nine time points over four hours. Analyte concentrations of glucose, insulin, triglycerides, and GLP-1, are used to construct response curves. The primary outcomes are the area under the curve (AUC) for each analyte (glucose, insulin, triglycerides, GLP-1) following each DSMT. This approach parallels a cardiac stress test: the stimulus (the meal) is a probe to expose individual variability in physiological function. Module 2 data will also be used to develop novel statistical and machine learning methods that produce individual and generalizable causal models of nutrition and health. Module 3 is a controlled feeding study (Intervention arm 2) that is implemented in the live-in/residential setting. A separate subset of Module 1 participants completes the same three diets (Diet A, B, C) as in Module 2, but while residing in a research setting with full supervision of intake, activity, and sleep. The same cohort randomization scheme as in Module 2 determines diet order. The residential environment in Module 3 provides the highest degree of experimental control, allowing isolation of physiological effects of diet composition. Participants undergo a diet-specific meal test (DSMT) as well as a liquid meal test (LMT) accompanied by a dose of acetaminophen after completing each of the diets. In addition, intake balance studies are conducted in this module using the doubly labeled water assessments and DXA for body composition. Data from Module 3 will help quantify and separate variance in the AI/ML models attributable to adherence and other community dwelling factors observed in Module 2 and enables rigorous and controlled comparison against causal relationships discovered in Module 2 data. In both Modules 2 and 3, participants are masked to the nutritional profile of each diet to minimize expectancy bias. Investigators and diet implementation staff are unmasked.

Interventions

OTHERDiet A

This diet has high amounts of fruits/vegetables, whole grains, and beans, moderate amounts of dairy, meat/poultry/eggs, nuts/seeds, and olive oil, and very low amounts of sugar sweetened drinks and desserts.

OTHERDiet B

This diet has high amounts of refined grains, meat/poultry/egg, sugar sweetened drinks, snacks, desserts, and processed foods. It has a moderate amount of dairy and low amounts of fruits/vegetables, whole grains, and fish.

OTHERDiet C

This diet has moderate-high amounts of vegetables, meat/poultry/egg, nuts/seeds, dairy and fats/oils, low amounts of fruits, and very low amounts of grains and sugars.

Sponsors

RTI International
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
University of North Carolina, Chapel Hill
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
Illinois Institute of Technology
CollaboratorOTHER
University of Chicago
CollaboratorOTHER
Pennington Biomedical Research Center
CollaboratorOTHER
Louisiana State University Health Sciences Center in New Orleans
CollaboratorOTHER
University of California, Davis
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
Cedars-Sinai Medical Center
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
Tufts University
CollaboratorOTHER
Massachusetts General Hospital
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
National Cancer Institute (NCI)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
City University of New York, School of Public Health
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
University of Hawaii
CollaboratorOTHER
Vanderbilt University Medical Center
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
National Institute of Drug Abuse
CollaboratorFED
Public Health Informatics Computational and Operations Research
CollaboratorUNKNOWN
University of Southern California
CollaboratorOTHER
Cornell University
CollaboratorOTHER
University of Alabama, Tuscaloosa
CollaboratorOTHER
North Carolina State University
CollaboratorOTHER
University of North Carolina, Charlotte
CollaboratorOTHER
Duke University
CollaboratorOTHER
Stevens Institute of Technology
CollaboratorOTHER
Purdue University
CollaboratorOTHER
United States Military Academy West Point
CollaboratorFED
USDA, Western Human Nutrition Research Center
CollaboratorFED
North Carolina Central University
CollaboratorOTHER
Wake Forest University Health Sciences
CollaboratorOTHER
Boston University
CollaboratorOTHER
Children's Hospital of Richmond
CollaboratorUNKNOWN
Virginia Commonwealth University
CollaboratorOTHER
Verily Life Sciences LLC
CollaboratorINDUSTRY
Indiana University
CollaboratorOTHER
Fred Hutchinson Cancer Center
CollaboratorOTHER
Columbia University
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Participants are masked to the 3 different diets (i.e., Diet A, Diet B, Diet C).

Intervention model description

Participants receive three standardized diets in a community-dwelling (Module 2) or live-in/residential settings (Module 3) setting.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Overall Inclusion -- Participants 18 years of age or older who have completed the primary All of Us consent process, Electronic Health Record consent process, have provided at least one All of Us biospecimen suitable for DNA sequencing, and have completed All of Us Participant Provided Information (PPI) Modules 1-3 (Basics, Overall Health, and Lifestyle); Speak English or Spanish; Able and willing to comply with study requirements and consent to participate. * Module 1 -- Must be willing and able to comply with Module 1 protocol; Must provide informed consent for Module 1. * Module 2 -- Must have completed Module 1; Must provide informed consent for Module 2; Must agree to comply with protocol over a period of approximately 10 to 12 weeks and up to six months. This includes consuming only the foods provided during periods of controlled feeding. Module 2 has three controlled feeding periods each lasting approximately two weeks with at least two weeks between feeding periods, and up to 6 months allowed for completion of the Module. * Module 3 -- Must have completed Module 1; Must provide informed consent for Module 3; Must agree to comply with protocol over a period of approximately 10 to 12 weeks and up to 6 months. This includes being domiciled three times, for two weeks each, and consuming only the foods provided during the domiciled periods. There is at least two weeks between domiciled periods, and up to 6 months allowed for completion of the Module.

Exclusion criteria

* Module 1 1. Any change to the participant's status from the time of All of Us enrollment that would render them ineligible for All of Us (e.g., being incarcerated, no longer living in the United States, or withdrawn from that study). 2. Inability to provide informed consent and engage in informed consent procedures 3. Participants who suffer from allergic reactions to, or are unwilling to consume, any components of the liquid mixed meal (e.g., milk products, soy products) 4. Barriers to safe insertion of peripheral IV canula: 1. Contraindications to peripheral IV canula insertion such as local skin infection, inflammation, trauma or burns if all the upper extremities were involved and there is no unaffected extremity available for IV placement; or 2. A need for long-term IV access (e.g., ESRD); or 3. Lymphedema or deep vein thrombosis (DVT) in the extremity of the IV (in the case where another extremity is not available); or 4. Coagulopathy requiring blood thinning products; or 5. Arteriovenous (AV) graft or fistula in the extremity of the IV (in the case where another extremity is not available) 5. Pregnancy-related conditions: 1. Gestational age precluding completion of the Module by 36 weeks. A pregnant participant should complete visit 1 by gestational age 34 weeks, 0 days and complete Module 1 by week 36. 2. Severe morning sickness limiting mixed meal tolerance test (MMTT) consumption 6. Certain types of disease states: 1. Dumping syndrome or inability to consume the volume of the MMTT liquid 2. Severe malabsorption such as history of short gut syndrome or need for parenteral or enteral nutrition 3. Less than 12-months post-metabolic or bariatric surgery 4. History of chronic pancreatitis (e.g., Cystic fibrosis) complicated by inability to tolerate the volume of the MMTT liquid 5. Health conditions requiring chronic blood transfusions or iron infusions 6. Hemoglobin \<9.5 g/dL at screening 7. Serious illness and in hospice or palliative care for terminal disease 8. Swallowing issues: 1. Self-reported difficulty tolerating solids or liquids 2. Aspiration risks that require change in thickness of liquid or dietary modifications 9. Short term antibiotic use. For example, active antibiotics use for an ongoing acute infection 10. Blood donation in the last 3 months 11. GLP-1 agonist medication (e.g. Semaglutide) instability as defined by less than 3 months of continuous use 12. Any disorder, unwillingness, or inability not covered by any other

Design outcomes

Primary

MeasureTime frameDescription
Glucose - Diet Specific mixed meal tolerance test (MMTT) Diet A4 hoursArea under the curve (AUC) for glucose measured during the diet-specific MMTT for Diet A.
Insulin - Diet Specific mixed meal tolerance test (MMTT) Diet A4 hoursArea under the curve (AUC) for insulin measured during the diet-specific MMTT for Diet A.
Triglycerides - Diet Specific mixed meal tolerance test (MMTT) Diet A4 hoursArea under the curve (AUC) for triglycerides measured during the diet-specific MMTT for Diet A.
GLP-1 - Diet Specific mixed meal tolerance test (MMTT) Diet A4 hoursArea under the curve (AUC) for Glucagon-Like Peptide-1 (GLP-1) measured during the diet-specific MMTT for Diet A.
Glucose - Diet Specific mixed meal tolerance test (MMTT) Diet B4 hoursArea under the curve (AUC) for glucose measured during the diet-specific MMTT for Diet B.
Insulin - Diet Specific mixed meal tolerance test (MMTT) Diet B4 hoursArea under the curve (AUC) for insulin measured during the diet-specific MMTT for Diet B.
Triglycerides - Diet Specific mixed meal tolerance test (MMTT) Diet B4 hoursArea under the curve (AUC) for triglycerides measured during the diet-specific MMTT for Diet B.
GLP-1 - Diet Specific mixed meal tolerance test (MMTT) Diet B4 hoursArea under the curve (AUC) for Glucagon-Like Peptide-1 (GLP-1) measured during the diet-specific MMTT for Diet B.
Glucose - Diet Specific mixed meal tolerance test (MMTT) Diet C4 hoursArea under the curve (AUC) for glucose measured during the diet-specific MMTT for Diet C.
Insulin - Diet Specific mixed meal tolerance test (MMTT) Diet C4 hoursArea under the curve (AUC) for insulin measured during the diet-specific MMTT for Diet C.
Triglycerides - Diet Specific mixed meal tolerance test (MMTT) Diet C4 hoursArea under the curve (AUC) for triglycerides measured during the diet-specific MMTT for Diet C.
GLP-1 - Diet Specific mixed meal tolerance test (MMTT) Diet C4 hoursArea under the curve (AUC) for Glucagon-Like Peptide-1 (GLP-1) measured during the diet-specific MMTT for Diet C.

Secondary

MeasureTime frameDescription
Accuracy of energy intake estimates from tool (ASA24, mFR, AIM-2, ASA24 record, mFR+ASA24) compared to known intake from objective measures.14 daysAgreement will be assessed between total daily energy intake in kilocalories reported via each dietary assessment tool and known intake from the intake-balance method using doubly labelled water and provided diets.
Accuracy of energy intake estimates from tool (ASA24, mFR, AIM-2, ASA24 record, mFR+ASA24) compared to measured intake from provided diets.14 daysAgreement between energy reported via each dietary assessment tool and measured intake from provided diets, in grams per day.
Accuracy of carbohydrate intake estimates from tool (ASA24, mFR, AIM-2, ASA24 record, mFR+ASA24) compared to measured intake from provided diets.14 daysAgreement between carbohydrate intake reported via dietary assessment tool and measured intake from provided diets, in grams per day.
Accuracy of protein intake estimates from tool (ASA24, mFR, AIM-2, ASA24 record, mFR+ASA24) compared to measured intake from provided diets.14 daysAgreement between protein intake reported via each dietary assessment tool and measured intake from provided diets, in grams per day.
Accuracy of fat intake estimates from tool (ASA24, mFR, AIM-2, ASA24 record, mFR+ASA24) compared to measured intake from provided diets.14 daysAgreement between fat intake reported via each dietary assessment tool and measured intake from provided diets, in grams per day.
Accuracy of dietary fiber intake estimates from tool (ASA24, mFR, AIM-2, ASA24 record, mFR+ASA24) compared to measured intake from provided diets.14 daysAgreement between dietary fiber intake reported via each dietary assessment tool and measured intake from provided diets, in grams per day.
Acceptability scales for ASA24 and Diet A14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for ASA24 and Diet B14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for ASA24 and Diet C14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for mFR and Diet A14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for mFR and Diet B14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for mFR and Diet C14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for AIM-2 and Diet A14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for AIM-2 and Diet B14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for AIM-2 and Diet C14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for ASA24 Record and Diet A14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for ASA24 Record and Diet B14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for ASA24 Record and Diet C14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for mFR+ASA24 and Diet A14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for mFR+ASA24 and Diet B14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."
Acceptability scales for mFR+ASA24 and Diet C14 daysResponses to questions on ease of use and tool preference. Principal outcomes will be "ease of use" and "willingness to use again."

Countries

United States

Contacts

CONTACTCarolyn P Huitema, MS
info@nutritionforprecisionhealth.org833-947-2583
PRINCIPAL_INVESTIGATORMarie G Gantz, PhD

RTI International

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026